Company Profile

CCL Biomedical Inc
Profile last edited on: 4/21/14      CAGE: 3DJH2      UEI:

Business Identifier: antimicrobial compounds
Year Founded
2002
First Award
2003
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

224 North Washington Street
Havre De Grace, MD 21078
   (410) 939-9356
   info@cclbiomedical.com
   www.cclbiomedical.com
Location: Single
Congr. District: 02
County: Harford

Public Profile

Formerly located in DE, CCL Biomedical, Inc. is developing and commercializing highly effective, patented antimicrobial compounds for improved health, safety and engineering. CCL Biomedical's antimicrobial compounds are customizable to meet the demands of a number of applications, including the textile, healthcare, and defense industries. CCL Biomedical, Inc. offers antimicrobial compounds and plastics for effective destruction of micro-organisms and biofilm control and will work with clients to develop solutions to address their individual needs. The firm's products and services offer superior protection of the workforce and improve and maintain the quality of life for individuals

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 1 DHA $149,616
Project Title: High Performance Antimicrobial Textiles
2009 2 NSF $563,713
Project Title: Biocidal Textiles for Active Infection Control
2008 1 NIH $100,000
Project Title: Biocidal Surfaces for Medical Hardware
2007 2 NSF $610,217
Project Title: Engineering of Non-leaching Antibacterial Surfaces and Textiles
2003 1 Navy $69,991
Project Title: Anti-Terrorism - Consequence Management and Recovery

Key People / Management

  Nina Lamba -- President